Cellebrite DI lowers FY2026 sales guidance range to $555M-$561M
Cellebrite DI cuts its FY2026 sales outlook to $555.000 million-$561.000 million from $565.000 million-$571.000 million, versus a $568.048 million estimate.
Story updates
11:33:42 AM UTC
SquawkNews
Cellebrite DI shares are trading lower after the company reported worse-than-expected Q2 sales results and issued Q3 sales guidance below estimates. Also, the company cut its FY26 sales guidance below estimates.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.